10-08-2016, 10:55 AM
Povetkin-Stiverne headed to Russia
World of Boxing won the WBC purse bid to stage the WBC interim heavyweight title fight between Alexander Povetkin vs Bermaine Stiverne with a bid of $3,165,000 today in New York City.
The WBC also issued a statement on Povetkin’s drug test that led to the cancellation of a clash between Povetkin and WBC champ Deontay Wilder:
…the WBC would like to clarify its August 17, 2016, ruling concerning the adverse result for Meldonium found in Mr. Povetkin’s April 27, 2016, urine sample. Since that ruling, questions have arisen about its meaning.
1. For the avoidance of doubt, the WBC hereby states that the WBC ruling was not intended to convey, and should not be construed as conveying, a conclusion about whether Mr. Povetkin did or did not take Meldonium after it became a banned substance on January 1, 2016.
2. The litigation pending between Wilder and Povetkin is going to trial in February of 2017. If Mr. Wilder prevails at that trial, the WBC shall afford Mr. Povetkin the opportunity to show that the trial’s result was not based on a finding that Mr. Povetkin ingested Meldonium after January 1, 2016. If Mr. Povetkin fails to make that showing the WBC shall: (a) withdraw recognition of Povetkin as Interim World Champion (if he wins that title); (b) withdraw any mandatory challenger status he might have; and © impose any penalties upon Mr. Povetkin as per the WBC Clean Boxing Program Protocol, which includes suspensions and fines.
World of Boxing won the WBC purse bid to stage the WBC interim heavyweight title fight between Alexander Povetkin vs Bermaine Stiverne with a bid of $3,165,000 today in New York City.
The WBC also issued a statement on Povetkin’s drug test that led to the cancellation of a clash between Povetkin and WBC champ Deontay Wilder:
…the WBC would like to clarify its August 17, 2016, ruling concerning the adverse result for Meldonium found in Mr. Povetkin’s April 27, 2016, urine sample. Since that ruling, questions have arisen about its meaning.
1. For the avoidance of doubt, the WBC hereby states that the WBC ruling was not intended to convey, and should not be construed as conveying, a conclusion about whether Mr. Povetkin did or did not take Meldonium after it became a banned substance on January 1, 2016.
2. The litigation pending between Wilder and Povetkin is going to trial in February of 2017. If Mr. Wilder prevails at that trial, the WBC shall afford Mr. Povetkin the opportunity to show that the trial’s result was not based on a finding that Mr. Povetkin ingested Meldonium after January 1, 2016. If Mr. Povetkin fails to make that showing the WBC shall: (a) withdraw recognition of Povetkin as Interim World Champion (if he wins that title); (b) withdraw any mandatory challenger status he might have; and © impose any penalties upon Mr. Povetkin as per the WBC Clean Boxing Program Protocol, which includes suspensions and fines.